By David Stout
Attorneys in New England reached a proposed $100 million settlement on Tuesday with the owners of the pharmaceutical operation that produced tainted drugs responsible for the 2012 nationwide meningitis outbreak that killed 64 people.
The $100 million deal will provide compensation to insurers and victims of the outbreak in accordance with a Chapter 11 plan filed by the owners of New England Compounding Pharmacy Inc., according to Bloomberg.
The outbreak, which infected more than 700 people, was largely blamed on a steroid administered by spinal injection that was produced by the company.
A judge must still approve the settlement along with a system that will distribute the funds to victims awaiting compensation.
More Must-Reads from TIME
- Breaking Down the 2024 Election Calendar
- How Nayib Bukele’s ‘Iron Fist’ Has Transformed El Salvador
- What if Ultra-Processed Foods Aren’t as Bad as You Think?
- How Ukraine Beat Russia in the Battle of the Black Sea
- Long COVID Looks Different in Kids
- How Project 2025 Would Jeopardize Americans’ Health
- What a $129 Frying Pan Says About America’s Eating Habits
- The 32 Most Anticipated Books of Fall 2024
Contact us at letters@time.com